Grifols SA (GRFS)
9.02
+0.38
(+4.40%)
USD |
NASDAQ |
Jan 21, 16:00
9.01
-0.01
(-0.11%)
After-Hours: 20:00
Grifols EPS Diluted (Quarterly): 0.2183 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | -1.207 |
| Autolus Therapeutics Plc | -0.2955 |
| Mereo BioPharma Group Plc | -0.0436 |
| Evaxion AS | -0.2862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 167.60M |
| Revenue (Quarterly) | 2.180B |
| Total Expenses (Quarterly) | 2.031B |
| Enterprise Value | 19.58B |
| Gross Profit Margin (Quarterly) | 39.33% |
| Profit Margin (Quarterly) | 7.69% |
| Earnings Yield | 6.81% |
| Operating Earnings Yield | 24.51% |
| Normalized Earnings Yield | 6.473 |